Medical Diagnostic Laboratories, LLC, a member of Genesis Biotechnology Group (GBG) company and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, has expanded its...
RemeGen today announced that the US Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application to initiate its US-based Phase II clinical...
Medable, Inc., the leading global platform for decentralized clinical trials, and AliveCor, the leader in AI-based, personal ECG technology, today announced a partnership to dramatically scale remote...
BioIQ, a healthcare engagement and clinical adherence technology platform company, and Matrix Medical Network, a clinical leader in supporting the needs of at-risk populations, announce the availability of...
As Tocagen heads into its reverse merger with privately-held Forte Biosciences, Inc., San Diego-based Denovo Biopharma swooped in to snap up that company’s retroviral replicating vector platform (RRV), including an asset that...
Pfizer and Germany-based BioNTech are collaborating on a messenger RNA vaccine against SARS-CoV-2, the novel coronavirus that causes COVID-19. The two companies have already begun Phase I/II clinical testing in Germany....
Cambridge, Massachusetts-based Thrive Earlier Detection released data from its DETECT-A study evaluating its blood test to screen for multiple types of cancers. The study was run by Johns Hopkins...
Gilead Sciences reported encouraging results from its clinical trial of remdesivir in COVID-19. The company announced topline results from the open-label, Phase III SIMPLE trial looking at 5-day and...
Austria-based imaging solutions provider EMTensor has partnered with the Swiss wireless RF technology provider QuantalRF, to jointly evaluate the latter’s Quantal technology for its advanced ET...
Lungpacer Medical has secured emergency use authorisation (EUA) from the US Food and Drug Administration for its novel Diaphragmatic Pacing Therapy System (DPTS) to immediately treat...
US-based implantable cardiac devices company AtaCor Medical has secured $25m in Series B financing, led by a corporate partner, to advance the development of its extracardiac...
SeaStar Medical has secured an investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to start a pilot study of Selective Cytopheretic...
Nestled in the Hillfoot Villages of Scotland’s Central Lowlands, the town of Alva is home to fewer than 5,000 people and perhaps most famous for its...
Governments and organizations around the world are mulling the use of hotly-debated “immunity passports” aimed at easing pandemic-related lockdowns and restrictions on movements. The certificates could...
WASHINGTON: Revealing that his administration is conducting “very serious” and “very strong” investigations into China’s role in the global coronavirus pandemic, US President Donald Trump said...
Copyright © 2024 Medical Buyer